Core A. Two Projects and one Core within this POI program receive support by the now well-established Core A. Indeed, the Program requires an effective Administrative Core component as a central element of fiscal and scientific coordination. With this, the four goals of Core A are as follows: 1) To coordinate the budgetary and fiscal aspects of the POI. The proposed Program involves direct cost disbursements to investigators of Projects 1 and 2, as well as Cores A and B;hence careful oversight represents an absolute administrative requirement. 2) To facilitate communication among investigators within the Program. This takes form through performance of a variety of functions ranging from regularly scheduled meetings between Program investigators to training of Project investigators by Program Cores. 3) To coordinate the goals and activities of the POI as a Program Executive Committee and respond to input provided by Extemal Advisors;individuals that provide on-site visits to the University of Florida as well as teleconferance based reviews;both for the purpose of maximizing the progress and success of the Program. 4) To organize the collection of human materials, generate appropriate data sets, provide statistical support to the Program, assure compliance with appropriate regulatory bodies and edicts (e.g., Instituional Review Board, Institutional Animal Care and Use Committee, Health Insurance Portability and Accountability Act, etc.) and facilitate communication of Program results. In addition to the aforementioned functions, the administrative staff of the Program will also be responsible for communication with the NIH staff, as well as for assistance with publications and presentation of Program results. The successful completion of these POI studies should continue to prove beneficial for improving our understanding of those events critical to the pathogenesis and natural history of TID, identifying markers that enhance our ability to monitor immune activities in the disease, and developing immunotherapies capable of preventing or reversing the disorder.

Public Health Relevance

Patients with TID, as well as those at risk for developing the disorder, stand to benefit from the research overseen by the Administrative Core A. This, through the Program's ability to provide knowledge leading to a better understanding of why the disease develops and ultimately, as well as the identification of a means to prevent and/or cure this disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI042288-16
Application #
8660584
Study Section
Special Emphasis Panel (ZAI1-PA-I)
Project Start
Project End
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
16
Fiscal Year
2014
Total Cost
$154,137
Indirect Cost
$51,265
Name
University of Florida
Department
Type
DUNS #
969663814
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Perry, Daniel J; Wasserfall, Clive H; Oram, Richard A et al. (2018) Application of a Genetic Risk Score to Racially Diverse Type 1 Diabetes Populations Demonstrates the Need for Diversity in Risk-Modeling. Sci Rep 8:4529
Chen, Yi-Guang; Mathews, Clayton E; Driver, John P (2018) The Role of NOD Mice in Type 1 Diabetes Research: Lessons from the Past and Recommendations for the Future. Front Endocrinol (Lausanne) 9:51
Kusmartseva, Irina; Beery, Maria; Philips, Tiffany et al. (2018) Hospital time prior to death and pancreas histopathology: implications for future studies. Diabetologia 61:954-958
Hu, Ronghua; Xia, Chang-Qing; Butfiloski, Edward et al. (2018) Effect of high glucose on cytokine production by human peripheral blood immune cells and type I interferon signaling in monocytes: Implications for the role of hyperglycemia in the diabetes inflammatory process and host defense against infection. Clin Immunol 195:139-148
Smith, Mia J; Rihanek, Marynette; Wasserfall, Clive et al. (2018) Loss of B-Cell Anergy in Type 1 Diabetes Is Associated With High-Risk HLA and Non-HLA Disease Susceptibility Alleles. Diabetes 67:697-703
Chen, Jing; Chernatynskaya, Anna V; Li, Jian-Wei et al. (2017) T cells display mitochondria hyperpolarization in human type 1 diabetes. Sci Rep 7:10835
Ratiu, Jeremy J; Racine, Jeremy J; Hasham, Muneer G et al. (2017) Genetic and Small Molecule Disruption of the AID/RAD51 Axis Similarly Protects Nonobese Diabetic Mice from Type 1 Diabetes through Expansion of Regulatory B Lymphocytes. J Immunol 198:4255-4267
Delitto, Daniel; Delitto, Andrea E; DiVita, Bayli B et al. (2017) Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment. Cancer Res 77:672-683
Posgai, Amanda L; Wasserfall, Clive H; Kwon, Kwang-Chul et al. (2017) Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice. Sci Rep 7:42372
Sebastiani, Guido; Ventriglia, Giuliana; Stabilini, Angela et al. (2017) Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression. Sci Rep 7:6897

Showing the most recent 10 out of 117 publications